Journal
CELL
Volume 115, Issue 2, Pages 151-162Publisher
CELL PRESS
DOI: 10.1016/S0092-8674(03)00771-2
Keywords
-
Categories
Funding
- NIA NIH HHS [AG23176-01, AG-14917-8] Funding Source: Medline
- NIDDK NIH HHS [DK52464, DK07646, DK45011] Funding Source: Medline
- PHS HHS [A124671] Funding Source: Medline
Ask authors/readers for more resources
The established function of thyroid stimulating hormone (TSH) is to promote thyroid follicle development and hormone secretion. The osteoporosis associated with hyperthyroidism is traditionally viewed as a secondary consequence of altered thyroid function. We provide evidence for direct effects of TSH on both components of skeletal remodeling, osteoblastic bone formation, and osteoclastic bone resorption, mediated via the TSH receptor (TSHR) found on osteoblast and osteoclast precursors. Even a 50% reduction in TSHR expression produces profound osteoporosis (bone loss) together with focal osteosclerosis (localized bone formation). TSH inhibits osteoclast formation and survival by attenuating JNK/c-jun and NFkappaB signaling triggered in response to RANK-L and TNFalpha. TSH also inhibits osteoblast differentiation and type 1 collagen expression in a Runx-2- and osterix-independent manner by downregulating Wnt (LRP-5) and VEGF (Flk) signaling. These studies define a role for TSH as a single molecular switch in the independent control of both bone formation and resorption.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available